SNCA and Parkinson disease: Parkinson’s disease (PD) is the second most common progressive neurodegenerative disease characterized by the aggregation of α-synuclein (α-syn) neuronal inclusions, and a massive loss of dopaminergic (DA) neurons [1, 2].